ClinicalTrials.Veeva

Find clinical trials for Colon Cancer in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Neoplasm Metastasis
Adenocarcinoma
Lung Cancer
Pancreatic Cancer

Colon Cancer trials near Valencia, VC, ESP:

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

using liquid biopsy to guide the post-surgical and post-adjuvant clinical management in 140 microsatellite stable Stage-III and T4N0 Stage-II colon...

Active, not recruiting
Colon Cancer
Drug: Capecitabine
Drug: CAPOX

Phase 2

IFOM ETS - The AIRC Institute of Molecular Oncology

Valencia, Spain and 10 other locations

Phase II study investigating the safety, tolerability and effect on disease reccurence of Foxy-5 as neo-adjuvant therapy in resected colon c...

Active, not recruiting
Colon Cancer
Procedure: Tumour resection (colon cancer surgery)
Drug: FOLFOX regimen

Phase 2

WntResearch

Valencia, Spain

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Enrolling
Colonic Neoplasms
Neoplasms, Colon
Drug: FOLFOX
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Valencia, Spain and 212 other locations

The purpose of this study is to measure tumor response to treatment with ompenaclid (RGX-202) in patients with previously treated RAS mutant advanced...

Enrolling
Metastatic Colon Cancer
Colorectal Cancer
Drug: FOLFIRI regimen
Drug: Ompenaclid (RGX-202)

Phase 2

Inspirna

Valencia, Spain and 27 other locations

and pembrolizumab) given together for the treatment of colorectal cancer that:is metastatic (spread to other parts of the body);has the cond...

Enrolling
Metastatic Colorectal Cancer
Biological: Pembrolizumab
Biological: Cetuximab

Phase 2

Pfizer
Pfizer

Valencia, Spain and 108 other locations

A phase Ib, open-label platform study of select drug combinations chosen in order to characterize safety and tolerability of each treatment arm teste...

Active, not recruiting
BRAF V600 Colorectal Cancer
Drug: TNO155
Biological: Spartalizumab

Phase 1

Novartis
Novartis

Valencia, Comunidad Valenciana, Spain and 17 other locations

plus BSC in participants with refractory metastatic colorectal cancer (mCRC). 691 participants were randomized to one of the following treat...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Colon Cancer
Drug: Fruquintinib
Drug: Placebo

Phase 3

HUTCHMED
HUTCHMED

Valencia, Spain and 152 other locations

tislelizumab or irinotecan that can be given to patients who have cancers with specific molecular alterations called MSIhi (Microsatellite I...

Enrolling
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
Drug: irinotecan
Biological: tislelizumab

Phase 1

Novartis
Novartis

Valencia, Comunidad Valenciana, Spain and 18 other locations

To assess:efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification,...

Enrolling
Colon Cancer
Lung Cancer
Drug: APL-101 Oral Capsules

Phase 2

Apollomics

Valencia, Spain and 90 other locations

Study 849-010 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab versus...

Active, not recruiting
Metastatic Colorectal Cancer
Advanced Colorectal Cancer
Drug: MRTX849
Drug: mFOLFOX6 Regimen

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Valencia, Spain and 308 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems